Judith K. Jones, MD, PhD

Dr. Jones is a clinical pharmacologist/epidemiologist trained in geriatrics and internal medicine with a longstanding interest in the study of adverse drug reactions, drug utilization, and drug development and regulation. She is the President and CEO of The Degge Group, Ltd. Dr. Jones is also the Executive Director and Chief Editor of DGI, Inc. as well as the President of The Pharmaceutical Education & Research
Institute, Inc. (PERI). She is a member of the Pharmacovigilance & Drug Safety Network.

Go to Programs or Faculty